Search

Susan X Qian

from East Boston, MA
Age ~62
Get Report
Also known as:
Xiuqi Q Qian, Xiu Qi Qian, Xui Q Qian, Susan Xiuqi Quan, Qi Qian Xiugi
Connected to:
Cen QianChelsea H Qian, 57Chunqi Qian, 44Crystal Qian, 29Elaine Y Qian, 61Fangzheng Qian, 34Feliks Qian, 57Flora F Qian, 51Guoqiang Qian, 57Haohua Qian, 61

Susan Qian Phones & Addresses

  • East Boston, MA
  • Cohoes, NY
  • 122 Baker Ave, Concord, MA 01742

Emails

s***[email protected]

Resumes

Resumes

Susan Qian Photo 1

Senior Director Process Sciences

View page
Location:
Boston, MA
Industry:
Biotechnology
Work:
Regeneron Pharmaceuticals, Inc.
Senior Director Process Sciences
Corning Incorporated
Plant Manager
Bd Oct 2008 - Oct 2012
Senior Program Manager
Shionogi Bioresearch Corp 1997 - 1999
Director, Assay Development and High Throughput Screening
Fuji Immuno Pharmaceuticals Corp 1993 - 1997
Assisstent Director of Drug Discovery
Education:
Julin University
Bachelors, Bachelor of Science, Chemistry Brandeis University
Doctorates, Doctor of Philosophy, Philosophy, Chemistry Harvard Medical School
Skills:
R&D
Cross Functional Team Leadership
Product Development
Medical Devices
Commercialization
Biotechnology
Life Sciences
Product Launch
Validation
Assay Development
Cell Culture
Pharmaceutical Industry
Fda
Manufacturing
Lifesciences
Technology Transfer
Design Control
Stem Cells
Gmp
Technology Evaluation
Product Management
Leadership
Program Management
V&V
Intellectual Property
Iso 13485
Six Sigma
Intellect
Strategy
Languages:
English
Mandarin
Susan Qian Photo 2

Yancheng Institute Of Technology

View page
Work:

Yancheng Institute of Technology
Education:
Yancheng Institute of Technology
Susan Qian Photo 3

Susan Qian

View page
Susan Qian Photo 4

Susan Qian

View page

Publications

Us Patents

Immunocytokine Sequences And Uses Thereof

View page
US Patent:
7169904, Jan 30, 2007
Filed:
Dec 16, 2003
Appl. No.:
10/737208
Inventors:
Stephen D. Gillies - Carlisle MA, US
Kin-Ming Lo - Lexington MA, US
Susan X. Qian - Concord MA, US
Assignee:
EMD Lexigen Research Center Corp. - Billerica MA
International Classification:
C07K 16/00
US Classification:
5303873, 5303879, 5303881
Abstract:
The invention provides a family of antibodies that specifically bind the human cell surface glycosphingolipid GD2. The antibodies comprise modified variable regions, more specially, modified framework regions, which reduce their immunogenicity when administered to a human. The antibodies may be coupled to a therapeutic agent and used in the treatment of cancer.

Recombinant Tumor Specific Antibody And Use Thereof

View page
US Patent:
7459538, Dec 2, 2008
Filed:
Jul 1, 2005
Appl. No.:
11/174186
Inventors:
Stephen D. Gillies - Carlisle MA, US
Kin-Ming Lo - Lexington MA, US
Susan Xiuqi Qian - Concord MA, US
Assignee:
Merck Patent GmbH - Darmstadt
International Classification:
C07K 16/00
US Classification:
5303873, 530350, 5303877, 5303917
Abstract:
The invention provides a family of antibodies that specifically bind the human epithelial cell adhesion molecule. The antibodies comprise modified variable regions, more specially, modified framework regions, which reduce their immunogenicity when administered to a human. The antibodies, when coupled to the appropriate moiety, may be used in the diagnosis, prognosis and treatment of cancer.

Immunocytokine Sequences And Uses Thereof

View page
US Patent:
7767405, Aug 3, 2010
Filed:
Nov 15, 2006
Appl. No.:
11/599687
Inventors:
Stephen D. Gillies - Carlisle MA, US
Kin-Ming Lo - Lexington MA, US
Susan X. Qian - Concord MA, US
Assignee:
Merck Patent GmbH - Darmstadt
International Classification:
G01N 33/53
C07K 16/00
US Classification:
435 71, 435 72, 435 723, 5303871, 5303873, 5303881
Abstract:
The invention provides a family of antibodies that specifically bind the human cell surface glycosphingolipid GD2. The antibodies comprise modified variable regions, more specially, modified framework regions, which reduce their immunogenicity when administered to a human. The antibodies may be coupled to a therapeutic agent and used in the treatment of cancer.

Recombinant Tumor Specific Antibody And Use Thereof

View page
US Patent:
7803618, Sep 28, 2010
Filed:
Aug 29, 2008
Appl. No.:
12/201935
Inventors:
Stephen D. Gillies - Carlisle MA, US
Kin-Ming Lo - Lexington MA, US
Susan Xiuqi Qian - Concord MA, US
Assignee:
Merck Patent GmbH - Darmstadt
International Classification:
C12N 5/10
US Classification:
435328, 435 691, 4353201, 435325, 5303873, 5303877, 53038822, 536 235
Abstract:
The invention provides a family of antibodies that specifically bind the human epithelial cell adhesion molecule. The antibodies comprise modified variable regions, more specially, modified framework regions, which reduce their immunogenicity when administered to a human. The antibodies, when coupled to the appropriate moiety, may be used in the diagnosis, prognosis and treatment of cancer.

Extracellular Matrix Coated Surface For Culturing Cells

View page
US Patent:
8241908, Aug 14, 2012
Filed:
May 11, 2007
Appl. No.:
11/747523
Inventors:
Susan X. Qian - Concord MA, US
Suparna Sanyal - Tewksbury MA, US
Assignee:
Becton, Dickinson and Company - Franklin Lakes NJ
International Classification:
C12N 5/00
US Classification:
435402, 435395
Abstract:
A cell culture product is provided for propagating embryonic stem cells, and maintaining their self-renewal and pluripotency characteristics for extended periods of time in culture. The cell culturing, product includes a substrate; and a coating thereon deposited, from a coating solution. The coating solution includes a mixture of extracellular matrix proteins and an aqueous solvent, wherein the total protein concentration in the coating solution is about 10 μg/ml to about 1 mg/ml.

Defined Cell Culturing Surfaces And Methods Of Use

View page
US Patent:
8288513, Oct 16, 2012
Filed:
Jul 24, 2009
Appl. No.:
12/508661
Inventors:
Suparna Sanyal - Tewksbury MA, US
Deepa Saxena - Framingham MA, US
Susan Xiuqi Qian - Concord MA, US
Elizabeth Abraham - Andover MA, US
Assignee:
Becton, Dickinson and Company - Franklin Lakes NJ
International Classification:
C07K 17/00
US Classification:
530350, 530353, 427447, 427488, 427533, 264483
Abstract:
In one aspect, there is provided a cell culturing substrate including: a cell culture surface having a film attached thereto, wherein the film includes one or more plasma polymerized monomers; and a coating on the film-coated surface, the coating deposited from a coating solution comprising one or more extracellular matrix proteins and an aqueous solvent, where the total extracellular matrix protein concentration in the coating solution is about 1 ng/mL to about 1 mg/mL.

Immunocytokine Sequences And Uses Thereof

View page
US Patent:
8470991, Jun 25, 2013
Filed:
Apr 27, 2010
Appl. No.:
12/768678
Inventors:
Stephen D. Gillies - Carlisle MA, US
Kin-Ming Lo - Lexington MA, US
Susan Xiuqi Qian - Concord MA, US
Assignee:
Merck Patent GmbH - Darmstadt
International Classification:
C07H 21/04
C12P 21/02
C07K 16/28
US Classification:
536 2353, 435 696, 5303873, 5303882
Abstract:
The invention provides a family of antibodies that specifically bind the human cell surface glycosphingolipid GD2. The antibodies comprise modified variable regions, more specially, modified framework regions, which reduce their immunogenicity when administered to a human. The antibodies may be coupled to a therapeutic agent and used in the treatment of cancer.

Cell Culture Surfaces Having Hydrogel Supported Proteins

View page
US Patent:
8574906, Nov 5, 2013
Filed:
Aug 8, 2008
Appl. No.:
12/188477
Inventors:
Xiaoxi (Kevin) Chen - Westborough MA, US
Susan X. Qian - Concord MA, US
Assignee:
Corning Incorporated - Corning NY
International Classification:
C12N 5/00
C12N 5/02
US Classification:
435402, 435395, 435397
Abstract:
A method is disclosed herein for treating a polymeric surface to define an improved cell culture surface. The method includes the steps of: coating the polymeric surface with a hydrogel; and attaching proteins to the hydrogel-coated surface. Advantageously, a method is provided which consistently produces improved cell culture surfaces that generally avoid bare spots and possible undesired protein absorption or cell differentiation.
Control profile
Susan X Qian from East Boston, MA, age ~62 Get Report